Paul Ruff

24.3k citations
160 papers · 8.9k · 3 hit papers · h-index 33

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Viral-associated cancers and disorders
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 34
    • Viral-associated cancers and disorders 25
    • Global Cancer Incidence and Screening 12
    • Cancer Immunotherapy and Biomarkers 7
    • Cancer Treatment and Pharmacology 7
    • Lung Cancer Treatments and Mutations 14

Paul Ruff

151 papers receiving 8.7k citations

Paul Ruff's Hit Papers

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen 2012 · 992 citations
9920+5+11Years since publication50010001.5k2.0k2.5k

Peers

Paul Ruff
Comparison fields: 5 of 142
  • Oncology 5.3k
  • Hepatology 1.2k
  • Cancer Research 972
  • Pathology and Forensic Medicine 1.1k
  • Pulmonary and Respiratory Medicine 1.7k
Replace Bert H. O’Neil with:
Bert H. O’Neil United States
Christos S. Karapetis Australia
David Khayat France
Sandro Pignata Italy
Robert W. Ross United States
Tim Maughan United Kingdom
Dongyun Yang United States
Chiun Hsu Taiwan
Eduardo Díaz‐Rubio Spain
Miriam Koopman Netherlands
Paul Ruff relative to Bert H. O’Neil United States Bert H. O’Neil's profile →
Citations per field
00.5×1.5×
Bert H. O’Neil · 1×
Citations per year

Countries citing papers authored by Paul Ruff

Since Specialization
Citations

This map shows the geographic impact of Paul Ruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ruff more than expected).

Fields of papers citing papers by Paul Ruff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Ruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ruff. The network helps show where Paul Ruff may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Ruff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Ruff Line = papers co-authored together Paul Ruff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Hit paper breakdown →
20092914
2
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Hit paper breakdown →
20101355
3
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Hit paper breakdown →
2012992
4 2014344
5 1999207
6 2007201
7 2013161
8 1990137
9 2000132
10 1991126
11 2008121
12 1997112
13 200791
14 198791
15 200971
16 201871
17 199971
18 199760
19 199358
20 201653

About Paul Ruff

Paul Ruff is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Pathology and Forensic Medicine, having authored 160 papers that have together received 8.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (34 papers), Viral-associated cancers and disorders (25 papers), Cancer Genomics and Diagnostics (14 papers), Lung Cancer Treatments and Mutations (14 papers), Global Cancer Incidence and Screening (12 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (5.3k citations), Hepatology (1.2k citations), Cancer Research (972 citations), Pathology and Forensic Medicine (1.1k citations) and Pulmonary and Respiratory Medicine (1.7k citations). Paul Ruff has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Eric Van Cutsem, G. Bodoky, Anatoly Makhson, Johannes Nippgen, Tamás Pintér, Robert Lim, Jae Kyung Roh, Gunnar Folprecht, Michael Schlichting and Claus-Henning Köhne. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, JCO Global Oncology and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact